{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiecpmzvkfdcjgglg4hbypa6eld22nfqnspfqbmq6nnoitex3o63wy",
    "uri": "at://did:plc:kpkcscbf2zshv7shqgqn45wn/app.bsky.feed.post/3mi5og77khjy2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig6woadcdi5wihywmqsow65kwspuzp5qzhylxfaszygkp5a74uyli"
    },
    "mimeType": "image/jpeg",
    "size": 1980
  },
  "path": "/story/385993/new-trend-in-weight-loss-drugs-casual-users.html",
  "publishedAt": "2026-03-28T16:52:06.000Z",
  "site": "https://www.newser.com",
  "textContent": "She didn't want to overhaul her body—just lose a few pounds. In New York magazine, Melissa Dahl profiles an emerging group of \"casual\" users of GLP-1 drugs like Ozempic, Wegovy, and newer compounds such as retatrutide. They are not obese, not diabetic, and often not working with a doctor...",
  "title": "New Trend in Weight-Loss Drugs: 'Casual' Users"
}